New conference tackles the tough questions in lung cancer

The First European Lung Cancer Conference will take place in Geneva, Switzerland from 23-26 April 2008. The meeting venue is the Geneva Palexpo, which is located 10 minutes from the city center, within walking distance from the Geneva International Airport and easily reachable by car and train.

A fully equipped press room will be in operation at the conference with Internet access and telephone lines for registered reporters. Journalists will have the possibility to schedule one-on-one interviews with top speakers and presenters of the studies, both in presence and remotely.

Please contact the ESMO Communication Dept. at to already find out about the preliminary timetable or to book a telephone hook up.

The conference full program is available at www.esmo.org/activities/jntconf/jntlung/prog_jntlung08/

To register for the conference as a media representative, please visit www.esmo.org/activities/jntconf/jntlung/registration_jntlun08/mediareg_jntlung08/ and send the Complimentary Media Registration form to the ESMO Head Office within Wednesday, 16 April to benefit from pre-registration. On-site registration will also be possible at the registration desks.

The European Society for Medical Oncology (ESMO) is the leading European non-profit, professional organization for medical oncology promoting multidisciplinary cancer treatment around the world.

ESMO unites medical oncologists and other oncology specialists, healthcare professionals, caregivers, patients, policy-makers and all the key stakeholders in a global alliance committed to eradicating cancer and ensuring equal access to high quality treatment for all patients. Through state-of-the-art education and training programs, ESMO plays an instrumental role in providing the oncology community with the most up-to-date scientific research and information available. ESMO is dedicated to educating and supporting oncologists, optimizing patient care, disseminating cancer-specific information to the public, and advocating patient rights. As an authoritative voice in the fight against cancer, ESMO provides both the platform and the consultative expertise to influence national and international organizations as well as European authorities, in order to establish common standards for a multidisciplinary approach to cancer treatment. Through its flagship journal, Annals of Oncology, ESMO publishes articles on all aspects of clinical oncology.

To find out more about ESMO please visit www.esmo.org

Founded in 1972, the International Association for the Study of Lung Cancer (IASLC) is an international organization of 2,000 lung cancer specialists, spanning 53 countries. IASLC members work towards developing and promoting the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer. IASLC's mission is to enhance the understanding end education of lung cancer to scientists, members of the medical community and the public. IASLC publishes the Journal of Thoracic Oncology, a prized resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.

To find out more about IASLC please visit www.iaslc.org